AKT1 and neoplasm: It has been shown to exert anti-angiogenic effects in ovarian tumors by inhibiting the VEGFR-2-mediated PI3K/Akt/eNOS signaling pathway [31] and interacting with the tumor suppressor BLU, resulting in pro-apoptotic activity in cervical and ovarian cancers [32].